ArticleCurrent oncology (Toronto, Ont.)2022

Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy.

Balázs Jóri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.